Sweden’s Innovation Agency (Vinnova) - Grant for Innovative Startup
Reccan Diagnostics are awared a grant of 300.000 SEK for their work to develop a diagnostic and prognostic biomarker test for pancreatic cancer in serum and cancertissue.
Reccan Diagnostics are awared a grant of 300.000 SEK for their work to develop a diagnostic and prognostic biomarker test for pancreatic cancer in serum and cancertissue.